future of glp-1 drugs What to Make the Coverage and Cost Landscape Drugmakers are only months into
Description
doi: 10.3389/fendo.2020.00178 [DOI] [PMC free article] [PubMed] [Google Scholar] 16.Mann JFE, Fonseca VA, Poulter NR, et al
3 Activation of the GLP-1 receptor (GLP-1R) by GLP-1 stimulates insulin release and inhibits glucagon secretion in a glucose-dependent manner
Tursi, S
In smaller acute metabolic studies with DPP-4 inhibitors, a reduction of the post-prandial rise in triglycerides, and apolipoprotein-B 48 was observed
doi:10.1111/dom.13847 266
1619 However, the clinical relevance of these direct myocardial effects in humans requires further clarification
